复星医药(02196.HK) (600196.SH) 与总部位于阿联酋阿布扎比的全球性生命科学公司Arcera签署合作备忘录,双方将聚焦全球生命科学领域的授权许可、技术开发、神经科学领域创新及价值创造,建立长期战略合作关系。根据合作备忘录,双方将在多个领域开展战略合作,在区域与全球市场许可合作方面,双方将评估及推动复星医药在中国已上市或处于临床后期的创新产品在中东及全球市场的授权与商业化,潜在...
Source Link复星医药(02196.HK) (600196.SH) 与总部位于阿联酋阿布扎比的全球性生命科学公司Arcera签署合作备忘录,双方将聚焦全球生命科学领域的授权许可、技术开发、神经科学领域创新及价值创造,建立长期战略合作关系。根据合作备忘录,双方将在多个领域开展战略合作,在区域与全球市场许可合作方面,双方将评估及推动复星医药在中国已上市或处于临床后期的创新产品在中东及全球市场的授权与商业化,潜在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.